Anthony P. Ford
Fondatore presso Afferent Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Anthony P. Ford
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
PharmNovo AB
 PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Anthony P. Ford tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer | |
| INTEL CORPORATION | Semiconductors | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| CASSAVA SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| KINEMED INC | Miscellaneous Commercial Services | Director/Board Member | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member | |
Vivace Therapeutics, Inc.
 Vivace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor | |
| Access Industries LLC | Corporate Officer/Principal | ||
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of Cape Town | College/University | Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Elfa International AB
 Elfa International AB Home FurnishingsConsumer Durables Elfa International AB manufactures and sells metal sheets and threads for storage solutions. It offers products and accessories for bedrooms, hallways, home offices, garages, living rooms, and kitchens. The company was founded by Arne Lydmar in 1948 and is headquartered in Vastervik, Sweden. | Home Furnishings | Chief Executive Officer | |
ProteomTech, Inc.
 ProteomTech, Inc. Miscellaneous Commercial ServicesCommercial Services ProteomTech, Inc. develops protein therapeutics. The private company is based in Emeryville, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Founder Director/Board Member | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Halda Therapeutics LLC
 Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TRex Bio Ltd.
 TRex Bio Ltd. BiotechnologyHealth Technology TRex Bio Ltd. is a British company that provides biotechnology research and development services. The private company is based in London, UK. The company was founded in 2018 by Houman Ashrafian. | Biotechnology | Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| Halda Therapeutics OpCo, Inc. | Director/Board Member | ||
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
| IO BIOTECH, INC. | Biotechnology | Chairman Director/Board Member | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Germania | 4 |
| Svezia | 3 |
| Danimarca | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 29 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Finance | 4 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 92 |
| Independent Dir/Board Member | 26 |
| Corporate Officer/Principal | 20 |
| Chief Tech/Sci/R&D Officer | 15 |
| Chief Executive Officer | 11 |
Contatti più connessi
| Insiders | |
|---|---|
| Jesse I. Treu | 38 |
| Liam Ratcliffe | 32 |
| Kevin Starr | 19 |
| K. Hirth | 18 |
| Kathleen Glaub | 13 |
| Michael M. Kitt | 11 |
| Bruce G. McCarthy | 8 |
| Peter G. Butera | 7 |
| Amy Pfeiffer | 5 |
| Göran Lerenius | 4 |
| Per von Mentzer | 3 |
| Hans G. Nilsson | 2 |
| Bengt von Mentzer | 1 |
| David Kendall | 1 |
- Borsa valori
- Insiders
- Anthony P. Ford
- Connessioni Società
